Angiodynamics (ANGO) Short-term Investments (2011 - 2018)

Angiodynamics' Short-term Investments history runs 8 years deep, the most recent figure standing at $1.3 million for Q4 2018.

• Quarterly Short-term Investments rose 7.14% year-over-year to $1.3 million in Q4 2018, while the trailing twelve-month figure through Nov 2018 was $1.3 million (up 7.14% YoY) and the FY2018 annual result came in at $1.3 million, up 8.4% from the prior year.
• Short-term Investments was $1.3 million for Q4 2018 at Angiodynamics, roughly flat from $1.3 million in the prior quarter.
• Across five years, Short-term Investments topped out at $1.8 million in Q2 2014 and bottomed at $1.2 million in Q4 2016.
• A 5-year average of $1.5 million and a median of $1.6 million in 2015 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2014 — Short-term Investments plunged 64.8% — and 2018, when it gained 11.11%.
• Angiodynamics' Short-term Investments stood at $1.7 million in 2014, then dropped by 3.47% to $1.6 million in 2015, then retreated by 26.6% to $1.2 million in 2016, then rose by 4.74% to $1.3 million in 2017, then gained by 7.14% to $1.3 million in 2018.
• Business Quant data shows ANGO's Short-term Investments at $1.3 million in Q4 2018, $1.3 million in Q3 2018, and $1.3 million in Q2 2018.